Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Jingming New Technological Development is a Chinese medical device company specializing in the development and manufacture of ophthalmic surgical materials. Founded in 1992 and headquartered in Tianjin, the company produces a range of products including intraocular lenses (IOLs) for cataract surgery, ophthalmic viscoelastic devices (OVDs) such as sodium hyaluronate, and medical gases like perfluoropropane used in vitreoretinal procedures. The company is a significant domestic supplier in the Chinese eye care market, providing essential consumables for both anterior and posterior segment surgeries. While it has a long history in the industry, it gained international attention due to a major 2015 recall of defective medical gas. Despite these challenges, the company remains an active participant in the ophthalmic supply chain in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tianjin Jingming Electronic Materials.